Doxorubicin liposomal User Reviews & Ratings
Brand names: Doxil
Doxorubicin liposomal has an average rating of 6.5 out of 10 from a total of 2 reviews on Drugs.com. 50% of reviewers reported a positive experience, while 0% reported a negative experience.
Condition | Avg. Rating | Reviews | Compare |
---|---|---|---|
Kaposi's Sarcoma | 1 reviews for Kaposi's Sarcoma | 9 medications | |
Ovarian Cancer | 1 reviews for Ovarian Cancer | 36 medications |
- Chi...
- Taken for 1 to 6 months
- September 18, 2021
Doxil (doxorubicin liposomal) for Kaposi's Sarcoma "Started end of June on the standard dose every two weeks (in combination with Biktarvy daily). Had a very large Kaposi's Sarcoma tumor on the eyelid and later discovered pulmonary lesions suspected to be KS related. One month later the tumor was in significant remission, I would say it is down in size by 2/3. After six cycles and given that I tolerate the drug very well, decided with the oncologist to go for 6 more cycles hoping for total remission of the eyelid tumor, and we will see next month about the suspected pulmonary involvement. To note: I live in a country with (near) universal health cover where the state pays for health care, save a small out-of-pocket co-payment, I think my participation is around 20 dollars per cycle."
Are you taking this medicine?
Your review helps others make informed decisions.More about doxorubicin liposomal
- Check interactions
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- Drug class: antibiotics/antineoplastics
- En español
For Ovarian Cancer "One year on this drug and now the CA markers are back elevated. The drug worked, maintained CA 125 marker for 7 months. I’m now meeting with the doctor to figure out the next treatment plan. I can’t take anything that is carboplatin-based as it causes profound hearing loss, and I’m already very hard of hearing. While on Doxil, my skin peeled, some pustules, but they healed after 3 months, loss of appetite, and minimal hair regrowth on the scalp. Overall, I tolerated this drug, but it’s not working for me, stage 4 ovarian cancer."